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ho–GTPase has been implicated in axon outgrowth.
However, not all of the critical steps controlled by
Rho have been well characterized. Using cultured
cerebellar granule neurons, we show here that stromal
 
cell–derived factor (SDF)-1
 
 
 
, a neural chemokine, is a
 
physiological ligand that can turn on two distinct Rho-
dependent pathways with opposite consequences. A low
concentration of the ligand stimulated a Rho-dependent
pathway that mediated facilitation of axon elongation. In
contrast, Rho/ROCK activation achieved by a higher con-
centration of SDF-1
 
 
 
 caused repression of axon formation
R
 
and induced no more increase in axon length. However,
even at this higher concentration a Rho-dependent axon
elongating activity could be recovered upon removal of
ROCK activity using Y-27632. SDF-1
 
 
 
–induced axon elon-
gating activity under ROCK inhibition was replicated by the
dominant-active form of the mammalian homologue of the
 
Drosophila
 
 gene Diaphanous (mDia)1 and counteracted by
its dominant-negative form. Furthermore, RNAi knock-
down of mDia1 abolished SDF-1
 
 
 
–induced axon elongation.
Together, our results support a critical role for an SDF-1
 
 
 
/
Rho/mDia1 pathway in mediating axon elongation.
 
Introduction
 
It has been widely accepted that rearrangement of actin and
microtubule cytoskeleton lies at the heart of neuronal mor-
phogenesis (Tanaka and Sabry, 1995). Drastic changes in
neuronal shape occur immediately after the exit of neuronal
cells from mitotic cycles, during embryonic and postnatal
development. Process formation/extension and cell body mi-
gration must be spatially and temporally orchestrated in order
to achieve patterned formation of neuronal cell layers and
appropriate generation of synaptic circuits (Goodman and
Shatz, 1993; Tessier-Lavigne and Goodman, 1996; Van
Vactor and Flanagan, 1999).
A dynamic morphological alteration is initiated during the
acquisition of neuronal polarity and must continue until the
completion of synaptogenesis. Recent findings indicate a critical
role for the antagonism between Rac– and Rho–GTPases in
these events (Narumiya et al., 1997; Hall, 1998; Luo, 2000;
Dickson, 2001). A large body of work has now established
that several soluble or transmembranous guidance molecule
systems can exhibit either chemorepulsion or chemoattraction
toward axonal growth cones, at least in part, via coupling to
either Rho or Rac, respectively. Such systems include EphrinA
(Shamah et al., 2001), EphB reverse signaling (Lu et al.,
2001), Sema4D/PlexinB (Driessens et al., 2001; Swiercz et
al., 2002), Sema3A/PlexinA-Neuropilin (Jin and Strittmatter,
1997; Liu and Strittmatter, 2001; Jurney et al., 2002), Netrin/
DCC (Li et al., 2002), Slit/Robo (Wong et al., 2001), and
neurotrophins/p75/trk (Yamashita et al., 1999; Huang and
Reichardt, 2001; Ozdinler and Erzurumlu, 2001; Nusser et
al., 2002). Thus, antagonistic interactions and hierarchical
cascades between distinct small GTPases had been considered
as most likely ways by which distinct gradient cues could be
decoded into reliable maps of afferents projecting into one
specific area of the central nervous system (CNS).*
However, to date, a clear understanding regarding what
specific effectors of the small GTPases contribute to each of
these opposing signaling events is still missing. Furthermore,
whether Rho always antagonized with Rac remains contro-
versial (Sebok et al., 1999; Bashaw et al., 2001).
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The rodent cerebellar granule cells represent a highly ad-
vantageous resource to study in detail the molecular se-
quence of events controlling axonogenesis, neuronal migra-
tion, dendritogenesis, and synaptogenesis. Indeed, each of
these steps that is critical for neuronal maturation and cir-
cuit formation occurs in an organized and sequential fashion
in the cerebellum during the postnatal 3 wk after birth (Alt-
man and Bayer, 1996; Hatten, 1999). Many of these steps
involve dramatic changes in neuronal morphology, yet pre-
vious studies indicated that many of their features could be
recapitulated, at least in part, in primary culture (Powell et
al., 1997; Bito et al., 2000; Yamasaki et al., 2001; Yacubova
and Komuro, 2002).
Previous investigation of molecular determinants involved
in axon formation in cerebellar granule cells, from our labo-
ratory and others, have begun to uncover the critical impor-
tance of pia–granule cell interaction (Bhatt et al., 2000) on
one hand and control of actin dynamics on the other (Bito
et al., 2000; Yamasaki et al., 2001). Thus, we considered the
possibility that a factor supplied by the pia mater may be in-
volved in the signaling pathway controlling axon initiation
and elongation. One candidate factor we tested was stromal
cell–derived factor (SDF)-1
 
 
 
, a chemokine heavily expressed
in the pia mater and chemoattractant for migration of cere-
bellar granule cells (Lu et al., 2001; Klein et al., 2001; Tham
et al., 2001; Zhu et al., 2002). Our interest was prompted
by the striking phenotype of the knockout mice lacking ei-
ther SDF-1
 
 
 
 (Ma et al., 1998) or its cognate receptor
CXCR4 (Ma et al., 1998; Zou et al., 1998). In both lines of
mice, the formation of the cerebellar granule cell layers was
abolished. This suggested that early events in cerebellar
granule cell morphogenesis, such as axon initiation, axon
elongation, or migration of the cell body, might be severely
perturbed in the absence of SDF-1
 
 
 
 signaling.
However, whether SDF-1
 
 
 
 could stimulate axon forma-
tion via direct control of actin cytoskeletal signaling mecha-
nisms in cerebellar granule cells has not been demonstrated.
Here we show that SDF-1
 
 
 
 activates Rho but not Rac small
GTPase in cerebellar granule cells. A low concentration (100
ng/ml) of SDF-1
 
 
 
 induced significant amount of axon out-
growth in a C3 exoenzyme–sensitive fashion. In contrast, at
a higher concentration SDF-1
 
 
 
 rather repressed axon for-
mation in a Rho-dependent manner. However, Y-27632
treatment was sufficient to uncover an axon elongating ac-
tivity even under high dose of SDF-1
 
 
 
. Thus, SDF-1
 
 
 
 stim-
ulated two distinct opposing Rho effectors: a novel Rho ef-
fector, which promoted axon elongation, and ROCK to
inhibit axonogenesis. The facilitatory effect of SDF-1
 
  
 
in
the presence of Y-27632 could be mimicked by overexpress-
ing a dominant-active (DA) form of the mammalian homo-
logue of the 
 
Drosophila
 
 gene Diaphanous (mDia)1, a Rho
effector involved in control of actin polymerization during
cell polarization and directed cell growth. This dominant ac-
tivation of mDia was dependent on intact Rac activity. Fur-
thermore, the axon outgrowth induced by SDF-1
 
 
 
 could be
antagonized either by overexpression of a dominant interfer-
ing mutant or by RNAi knockdown of mDia1. Thus, we
identify a novel function for mDia1 as a critical Rho effec-
tor–mediating SDF-1
 
 
 
–dependent axon elongation in con-
cert with Rac.
 
Results
 
A pial chemokine SDF-1
 
 
 
 triggers axon elongation via 
Rho early in culture in cerebellar granule cells
 
We tested whether SDF-1
 
 
 
 was able to trigger any axon
growth and whether this morphological change correlated,
at least in part, with an alteration in either Rho or Rac activ-
ity in cultured cerebellar granule cells, where axonogenesis is
well known to precede dendritogenesis. A 12-h exposure to
SDF-1
 
 
 
 at a concentration of 100 ng/ml induced a signifi-
cant increase in the mean length of first appearing pro-
cess compared with control (Fig. 1, A and B; Video 1, avail-
Figure 1. SDF-1  facilitates axon elongation via a Rho-dependent 
pathway. (A) Facilitation of axon elongation by 12-h exposure to 
SDF-1  (top). SDF-1 –induced facilitation is blocked by C3 treatment 
(bottom), indicating the existence of a Rho-dependent mode of neurite 
extension.  -tubulin immunostaining was employed to completely 
trace the entire length of axons. (B) Axon elongating activity induced 
by SDF-1  reveals a bell-shaped response curve, whereas axon 
numbers are reduced at only higher concentrations. SDF-1  effect 
on axon length and number are both blocked by C3 treatment. 
n   42–209. (C) 1- or 12-h exposure to SDF-1  (100 or 500 ng/ml) 
leads to a substantial increase in the amount of GTP-bound Rho 
(RBD pulldown) but not that of GTP-bound Rac (unpublished data) 
in cerebellar granule cells. **P   0.01; ***P   0.001. Bar, 5  m.T
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able at http://www.jcb.org/cgi/content/full/jcb.200210149/
DC1), while having no effect on axon number (Fig. 1, A and
B). This effect was abolished in the presence of C3 exoen-
zyme, a Rho inhibitor (Fig. 1, A and B). SDF-1
 
 
 
 promoted a
bell-shaped response in axon elongation with a peak effect at
100 ng/ml (Fig. 1, A and B). However, at a larger concentra-
tion this axon outgrowth effect was abolished and indistin-
guishable from the control (Fig. 1 B). In contrast, SDF-1
 
 
 
treatment significantly reduced axon number at concentra-
tions over 250 ng/ml. Presence of C3 exoenzyme completely
flattened either response (Fig. 1 B). Together, this indicated
that SDF-1
 
 
 
 may promote axon elongation via Rho, at least
at lower concentrations, whereas it inhibited initiation of
axon at higher concentrations. The reduction in SDF-1
 
 
 
–
dependent axon growth with the maximal concentration of
SDF-1
 
 
 
 was unlikely to be caused by receptor desensitization
or inactivation, since we confirmed that axon numbers were
now negatively affected at the same dose. Furthermore, either
1- or 12-h exposure to either 100 or 500 ng/ml SDF-1
 
 
 
 was
accompanied with a similarly strong elevation in the amount
of GTP-bound form of Rho (Fig. 1 C), whereas no apparent
increase was discerned for GTP-bound Rac (unpublished
data) as determined by pull-down assays using either a GST-
fused Rho-binding domain (RBD) of Rhotekin or a GST-
fused Cdc42/Rac interactive binding (CRIB) domain of p21-
associated kinase (PAK) were performed (Ren et al., 1999;
Tsuji et al., 2002). These results indicate the possibility that
stimulation of Rho pathway with a physiological ligand such
as SDF-1
 
 
 
 may mediate axon elongation.
 
Antagonism between a Rho-activated axon elongating 
pathway and ROCK-mediated control of axonogenesis
 
To test whether the biphasic responsiveness could be ac-
counted for by the existence of distinct thresholds of activa-
tion of two separate Rho effectors, we carefully reexamined
the dose–response relationship between C3 concentration
and resulting axon length. The sampling number was in-
creased substantially in order to detect even small differences
that might have been overlooked before. At 10 
 
 
 
g/ml of C3,
a significant increase in axon length and number was
achieved (Fig. 2). When the dose was augmented to 30–50
 
 
 
g/ml, this facilitation in axon length was substantially di-
minished compared with 10 
 
 
 
g/ml treatment, though a
small but significant net increase was still detectable; how-
ever, no additional effect was seen on axon number (Fig. 2).
Therefore, different concentrations of active Rho were likely
to gear two distinct pathways, repression and facilitation of
axon extension, via two distinct Rho effectors. In contrast,
only one Rho effector was likely to contribute to axon num-
ber control (Fig. 2), consistent with our previous work (Bito
et al., 2000). A similar C3 dose–response curve was also re-
ported in PC-12 cells (Winton et al., 2002).
What are these two Rho effectors? The finding that SDF-
1
 
 
 
 seemed to antagonize axonogenesis at higher doses in a
Rho-dependent manner (Fig. 1 B) was in keeping with our
previous finding that Rho/ROCK signaling critically regu-
lates axon numbers (Bito et al., 2000). To test whether
ROCK, a Rho-associated kinase (Narumiya et al., 1997; Bito
et al., 2000; Ishizaki et al., 2000), was indeed mediating the
SDF-1
 
 
 
 effect, we bath-applied 50 
 
 
 
M Y-27632, a potent
and selective ROCK inhibitor (Uehata et al., 1997; Ishizaki
et al., 2000). As expected, treatment with Y-27632 reversed
the negative SDF-1
 
 
 
 effect on axon numbers, indicating that
SDF-1
 
 
 
 is indeed able to activate ROCK (Fig. 3, A and B).
Surprisingly, however, exposure to SDF-1
 
 
 
 in the presence
of the ROCK inhibitor now resulted in a significant net in-
crease in axon extension (Fig. 3, A and B). Thus, SDF-1
 
 
 
 ac-
tivated a novel ROCK-independent, yet C3-sensitive, effec-
tor pathway that was coupled to axon elongation.
Figure 2. Distinct C3 dose effectiveness on axon elongation and 
axon number in cultured cerebellar granule neurons. Axon elongation 
reveals a bell-shaped C3 responsiveness consistent with the presence 
of two opposing effects downstream of Rho. However, the C3 effect 
on axon number is saturated at doses over 10  g/ml. n  115–424; 
***P   0.001.
Figure 3. SDF-1 –induced axon elongation is antagonized by 
ROCK. 12-h exposure to high concentration (500 ng/ml) of SDF-1  
represses axonogenesis (A, top, and B, right). Addition of 50  M 
Y-27632, a specific ROCK inhibitor, blocked this SDF-1 –induced 
inhibition of axonogenesis (A, bottom, and B, right). Under the same 
condition, SDF-1  significantly facilitated axon elongation in 
ROCK-inhibited neurons (B, left), while having little effect on axon 
numbers (B, right). n   82–74. ***Compared with untreated cells or 
###compared with Y-27632-treated cells; P   0.001. Bars, 5  m.T
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The Rho effector mDia1, a regulator of actin 
polymerization, is heavily expressed in the external 
granule cell layer during early postnatal development 
and positively regulates axon outgrowth
 
Recently, mDia was found to be a critical Rho effector that
may predominantly act as an inducer/regulator of actin
polymerization in HeLa cells and may be required for es-
tablishment of cell polarity and directed growth (Wa-
tanabe et al., 1997; Ishizaki et al., 2001; Ozaki-Kuroda et
al., 2001; Tsuji et al., 2002). Indeed, we found that
Swiss3T3 cells can elongate prolonged neurite-like pro-
cesses best when higher mDia activity was achieved by
overexpression a DA form of mDia1 (mDia1-
 
 
 
N3; Fig. 4
A; Ishizaki et al., 2001) and was coupled with lower
ROCK activity in the presence of 30 
 
 
 
M Y-27632 (Fig. 4
B), consistent with previous work from our laboratory
(Tsuji et al., 2002).
We also found that expression of mDia1 coincided with
early axonogenesis in postnatal cerebellum in mice (Fig.
5, A and B). Immunohistochemical analysis showed that
mDia1 was especially abundant in postnatal day 1 (P1) cer-
ebellum at and beneath the external granule cell layer where
the earliest events in axonogenesis occurred (Fig. 5 B). In
round cerebellar granule cells, mDia1 protein was already
colocalized with F-actin and tubulin at spots where an axon
was likely to initiate (Fig. 5 C). After axon outgrowth
started, mDia1 was heavily enriched at the base of early ini-
tiating process and within its growth cones (Fig. 5 C, ar-
rowheads) in close spatial vicinity with actin filaments and
microtubules (Figs. 5 C).
Figure 4. A putative role for mDia1 in 
facilitated process outgrowth. (A) Domain 
structure of wild-type and dominant mutant 
constructs of mDia1. (B) Coupling of elevated 
mDia1 activity (by overexpression of mDia1-
 N3) with lower ROCK activity (in the presence 
of Y-27632) is sufficient to induce elongated 
axon-like processes in Swiss3T3 cells. Note the 
high amount of F-actin stained with phalloidin 
in the thin processes (arrowheads) of the GFP-
mDia1- N3–expressing cells. Bars, 50  m.T
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To ask directly whether mDia1 activity facilitated, at least
in part, axon formation and elongation in cerebellar granule
neurons, we tested whether expression of the DA-mDia1
mutant was sufficient to replicate the SDF-1
 
 
 
–induced
axon elongating activity in the absence of ROCK pathway
which was blocked with Y-27632. Transfection was per-
formed immediately after trituration and during initial plat-
ing of the neurons so that expression of exogenous protein
was initiated 
 
 
 
6 h after plating (Bito et al., 2000, and this
study). Neurons were fixed using PFA at 12 h after transfec-
tion to examine the effect of mDia1 activity on axon initia-
tion and elongation. Indeed, mDia1-
 
 
 
N3–expressing cere-
bellar granule cells revealed a similar number of axons as
GFP-expressing control cells; however, the axons were sig-
nificantly longer compared with the mock-transfected neu-
rons in the presence of Y-27632 (Fig. 6, A–D), consistent
with the idea that mDia1 may work downstream of Rho to
facilitate axon growth.
During transfection of mDia1-
 
 
 
N3, we noticed that the
newly formed processes were abnormal in neurons untreated
with Y-27632. Axon outgrowth seemed to be prematurely
aborted as processes were filled with an exuberant amount of
filamentous actin and 
 
 
 
-tubulin (Fig. 6 B, mDia1-
 
 
 
N3),
and thus exhibited an abnormal width (Fig. 6 B and unpub-
lished data). Basal ROCK activity, in the context of exces-
sive mDia1 activity, might account for a prominent increase
in actin polymerization (Watanabe et al., 1999), while also
sustaining a tonic level of actomyosin contractility, thereby
negatively acting on axon elongation.
 
Rho/mDia pathway mediates SDF-1
 
 
 
–stimulated axon 
elongation in cerebellar granule neurons in part via a 
coordination with a Rac-dependent pathway
 
We next examined the contribution of endogenous mDia1
on SDF-1
 
 
 
–stimulated axon elongation by use of a domi-
nant-negative (DN) form of mDia1, mDia1-
 
 
 
N3(Hind-
III) (Fig. 4 A; Tsuji et al., 2002). This mutant was able to
abolish the effect of DA-mDia1 on axon length (Fig. 7 A).
DN-mDia1 also inhibited axon numbers back to baseline
levels (Fig. 7 A); however, since DA-mDia1 had little effect
per se (Fig. 6 D), we currently favor the simplest view that
rather than acting on the axonogenesis itself, mDia’s axon
elongating activity may be required in order to visualize
even the smallest process. Consistently, when this DN mu-
tant was transfected in neurons stimulated with SDF-1  in
the presence of Y-27632, both axon number and axon
length were significantly diminished (Fig. 7, B and C). To-
gether, these results support the notion that axon elonga-
tion induced by SDF-1  may be regulated in an mDia-
dependent manner.
To obtain an independent confirmation of these results,
we applied the RNA interference techniques using short in-
terfering double stranded RNA oligomers (siRNAs) (El-
bashir et al., 2001). mDia1-specific siRNA was designed
and its efficiency in knocking down mDia1 protein was
tested in NIH3T3 cells by Western blot analysis (Fig. 8 A).
Loss of mDia1 immunoreactivity was specifically obtained
in cells expressing a cotransfection marker enhanced GFP
(EGFP; unpublished data). Using identical transfection
procedures, EGFP-positive cerebellar granule neurons were
screened to identify the neurons, which have taken up the
mDia1 siRNA, and axon lengths were measured in these
neurons. A significant reduction was observed both in axon
numbers and in axon length (Fig. 8, B and C), compared
with scramble siRNA-treated neurons, in keeping with the
DN approach.
We finally wanted to examine the relevance of mDia1 ac-
tivity vis-a-vis of Rac, a small GTPase classically found to
mediate axon outgrowth. A DN form of Rac, RacN17, was
introduced into cerebellar granule cells along with a DA-
mDia1 mutant mDia1- N3. Axon elongation facilitated
by DA-mDia1 in the presence of Y-27632 was repressed, in
the presence of RacN17, back to baseline levels (Fig. 9 A).
These findings are most consistent with the idea that Rac
may significantly contribute to the mDia effect on axon
outgrowth. Thus, mDia may directly regulate Rac or one of
its upstream regulators.
Could Rho/mDia pathway regulate Rac? We recently pro-
posed a candidate mechanism in HeLa and Swiss3T3 cells:
as ROCK is known to down-regulate Rac activity, ROCK
inhibition, under some circumstances, may suffice to up-
regulate Rac via mDia1 (Tsuji et al., 2002). We tested
whether such a possibility may be true in cerebellar granule
Figure 5. High expression of mDia1 in cerebellar EGL during 
early postnatal development. (A) Western blot analysis of mDia1 
expression in cerebellar lysates at P1, P2, P9, or in adult (A). (B) 
mDia1-like immunoreactivity is highly concentrated at and beneath 
the EGL at P1. TO-PRO nuclear stain indicates the locations of the 
cells. Bar, 50  m. (C) mDia1 is highly expressed at the neck of a 
nascent process (top, arrowhead) or in the growth cones (bottom, 
arrowheads) in cerebellar granule cells in culture at 6 h (top) and 
12 h (bottom) in vitro. mDia1 heavily colocalized with F-actin 
(phalloidin) and microtubules (tubulin) structures. Bars, 5  m.T
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Figure 6. DA mDia1 facilitates axon elongation. Morphology of cerebellar granule cells overexpressing GFP (A), GFP-mDia1- N3 alone (B), 
or GFP-mDia1- N3 in the presence of Y-27632 (C). When ROCK activity was reduced, expression of GFP-mDia1- N3 resulted in a significantly 
enhanced elongation (D, left) of axons (n   65–157) compared with EGFP-expressing controls (A). Overexpression of GFP-mDia1- N3 alone 
successfully induced an axon, which, however, exhibited a significantly altered shape (enlarged width, premature stop), presumably due to an 
increased actin stability in the presence of intact ROCK activity (B). Basal ROCK activity, in the context of excessive mDia1 activity, might 
cause a prominent increase in actin polymerization, while also sustaining a tonic level of actomyosin contractility, thereby negatively acting 
on axon elongation. *P   0.05; ***P   0.001. Bars, 5  m.
Figure 7. A DN mDia1 mutant interferes 
with SDF-1 –dependent axon elongation. 
(A) Coexpression of the GFP-mDia1-
 N3(HindIII) mutant abolished the effect 
of FLAG-mDia1- N3 expression on axon 
length (left). n   33–80. (B and C) The 
effect of GFP-mDia1- N3(HindIII) 
overexpression was examined on 
SDF-1 –facilitated axon elongation 
in the presence of Y-27632. A potent 
inhibition on both SDF-1 –dependent 
axon elongation (B and C, left) and axon 
initiation (B and C, right) was detected. 
n   35–145. Bars, 5  m.T
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cells. Consistent with previous work, Y-27632 treatment in
SDF-1 –stimulated neurons was sufficient to increase the
GTP-bound form of Rac (Fig. 9 B).
Together, our data establish a critical role for the Rho/
mDia1 pathway in mediating axon elongation in SDF-1 –
stimulated cerebellar granule neurons, presumably in con-
cert with Rac activity (Fig. 10).
Discussion
Discovery of a Rho/mDia-dependent signaling 
pathway crucial for axon elongation
Previous reports have shown an antagonism between Rac-
and Rho-mediated pathways in neurite extension and con-
trol of axonal growth cones (for review see Narumiya et al.,
1997; Gallo and Letourneau, 1998; Hall, 1998; Luo, 2000;
Dickson, 2001; Nikolic, 2002). In the mammalian CNS, we
showed that enhanced Rho/ROCK activity led to inhibition
of axonogenesis, whereas inhibition of Rho/ROCK pathway
induced precocious outgrowth of neurites (Bito et al.,
2000). In spite of a few reports suggesting a distinct, rather
facilitatory effect for Rho during neuritogenesis (Threadgill
et al., 1997; Sebok et al., 1999; Bashaw et al., 2001), it has
remained unclear whether these experimental results truly
reflected a genuine primary effect mediated by Rho.
In this study, we have formally demonstrated that Rho
may in fact mediate both stimulation and inhibition of axon
outgrowth downstream of the same ligand SDF-1  in the
context of early postnatal cerebellar granule cells. Although a
classically recognized Rho/ROCK pathway repressed axon
formation, a Rho/mDia pathway was identified which rather
potently facilitated axon elongation. How ROCK can domi-
Figure 8. mDia1 knockdown by RNAi 
using siRNA completely abolishes 
SDF-1 –dependent axon elongation. 
(A) Significant reduction of mDia1 protein 
is achieved in NIH3T3 within 24 h by 
RNAi using siRNA. (B and C) mDia1 
knockdown by RNAi annihilates both 
SDF-1 –dependent axon elongation 
(C, left) and axon initiation (C, right) back 
to baseline levels, thereby confirming 
the DN experiments. n   26–140. 
***P   0.001. Bars, 5  m.
Figure 9. Expression of the morphological effects of mDia1 is 
mediated, at least in part, by Rac activity. (A) Co-expression of 
GFP-N17Rac, a DN mutant of Rac, suppresses expression of the 
facilitatory effects of FLAG-mDia1- N3 on either axon length (left) 
in the presence of Y-27632 (50  M) back to baseline levels. 
n   45–137. (B) Inhibition of ROCK activity in the presence of high 
concentration of SDF-1  (500 ng/ml) increases the GTP-bound form 
of Rac. ***P   0.001.T
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nantly antagonize the expression of the axon elongation ma-
chinery, while another Rho effector mDia is facilitating this
event, is currently being investigated. One possibility that is
consistent with our finding is that ROCK and mDia1 may
locally respond to different levels of GTP-bound Rho. Our
finding of a multiplicity in Rho-mediated sites of action is
reminiscent of the recent findings suggesting that Rac also
acts on multiple steps of axon outgrowth during Drosophila
development (Ng et al., 2002).
How then does mDia, an adaptor protein containing mul-
tiple formin homology domains, exert its effect on axon
elongation? A clear picture is still missing, since only a few
binding partners of mDia such as profilin (Watanabe et al.,
1997), IRSp53 (Fujiwara et al., 2000), or mDia-interacting
protein (Satoh and Tominaga, 2002) have been reported.
Interestingly, in Saccharomyces cerevisiae the Diaphanous ho-
mologue Bni1p was shown to be critically involved in con-
trolling assembly of actin cables required for establishment
of cell polarity and directed growth (Ozaki-Kuroda et al.,
2001; Pruyne et al., 2002; Sagot et al., 2002). Furthermore,
recently a DA mutant of mDia1 was also shown to affect
orientation of microtubules in HeLa cells, thus implying
that mDia may perhaps spatially coordinate actin polymer-
ization and the stability/rate of assembly of microtubule
polymers (Ishizaki et al., 2001; Palazzo et al., 2001).
Intriguingly, in our study Rac activity was shown to be re-
quired to support an mDia-based change in neuronal mor-
phology. Indeed, a high amount of basal Rac activity is found
in the early postnatal cerebellum (unpublished data). In vivo
and in vitro studies examining the consequence of defects in
Rac/Pak/Cdk5/p35 signaling have provided numerous lines
of evidence in support for a role for Rac-mediated control of
cytoskeletal dynamics during axon outgrowth (Luo et al.,
1994, 1996; Nikolic et al., 1996, 1998; Kaufmann et al.,
1998; Hing et al., 1999; Newsome et al., 2000; Zukerberg et
al., 2000; Ng et al., 2002). Since we detected an increase in
Rho but not Rac activity upon SDF-1  stimulation, we pre-
sume that Rac may play a rather permissive role in mediating
the Rho/mDia-dependent events, although we cannot ex-
clude the possibility that mDia may also directly regulate Rac
or one of its upstream regulators (Fig. 9; Tsuji et al., 2002).
A critical role for a pial chemokine SDF-1  as a 
guidance molecule regulating axon outgrowth
Recently, SDF-1  (Tashiro et al., 1993; Nagasawa et al.,
1994) has attracted a lot of attention as a prototypical
chemokine that acts as a mitogen and participates in posi-
tional control of a large variety of highly differentiated cell
types. Gene targeting of either the ligand molecule SDF-1 
or its receptor CXCR4 resulted in a strikingly similar pheno-
type in the respective knockout mice, thereby demonstrating
a crucial role for SDF-1 /CXCR4 signaling in the develop-
ment of appropriate cell layer formation in the cerebellum,
the hippocampal dentate gyrus, the thymus, the spleen, vas-
cular endothelium, and the intestinal epithelium (Nagasawa
et al., 1996; Ma et al., 1998; Tachibana et al., 1998; Zou et
al., 1998; Lu et al., 2002). In the cerebellum, absence of
SDF-1 /CXCR4 signaling resulted in premature invasion of
many proliferating granule cells into the cerebellar anlage,
and aberrant onset of migration from the external granule cell
layer (EGL) to the internal granule cell layer (IGL) (Ma et al.,
1998; Zou et al., 1998). Complementary experiments dem-
onstrated that SDF-1  acted as a chemoattractant for migra-
tion of both EGL- and IGL-derived cerebellar granule cells in
culture (Klein et al., 2001; Lu et al., 2001; Zhu et al., 2002).
Together, these lines of evidence are consistent with the idea
that neuronal migration and patterning may heavily involve
chemokine and G protein–coupled receptor signaling.
However, it was not known which exact step of neuronal
morphogenesis was directly targeted by SDF-1 , nor was it
clear what intracellular signaling it activated in order to ful-
fill its role as a neural guidance molecule. Here we found
that a large part of the initial morphogenetic and cytoskele-
tal action of SDF-1  might be specifically mediated by the
Rho signaling pathway, independent of its potency as a mi-
togen, in a pertussis toxin-insensitive manner (unpublished
data). Previously, it was suspected that SDF-1  might ex-
hibit its growth promoting or chemotactic effect on neurons
via pertussis-sensitive Gi/o heterotrimeric G proteins (Klein
et al., 2001) and/or via PLC-mediated activation of intracel-
lular calcium stores (Klein et al., 2001; Lu et al., 2002). The
possible contribution of these signaling pathways to the neu-
rite elongation still needs to be properly addressed in our
cultured cerebellar granule neurons.
Figure 10. Proposed model for the role of mDia in SDF-1 –
dependent axon outgrowth in cultured cerebellar granule neurons. 
Usually Rho and Rac antagonistically controls axon outgrowth. 
During the very early stages in the primary culture, ROCK action 
predominates to favor suppression of precocious outgrowth of 
axons from the cerebellar granule cells. However, as these neurons 
express a high amount of mDia1 gradual decline in ROCK activity 
facilitates expression of Rho-dependent mDia1 activity and a 
subsequent recruitment of a signaling complex, which in concert 
with the Rac-dependent signaling cascade may help the transition 
from inhibition to stimulation of axon outgrowth and elongation. 
Thus, the SDF-1 /Rho/mDia1 pathway may play a critical role in 
defining and modulating the balance between the Rho- and Rac-
based signaling pathways during axon outgrowth.T
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Control of actin dynamics via multiple effectors of 
small GTPases: potential antagonism and coordination 
between distinct signaling pathways
Our study demonstrates that the Rho-dependent signaling
cascade implicated in the developmental control of neural
hardwiring may consist of two apparently opposing streams
of signals: an inhibitory pathway mediated by ROCK (Bito
et al., 2000) and a facilitatory pathway mediated by mDia1
(this study). Coordination of these two pathways may be
suited to sequentially express the unique property of SDF-1 
either as a repellant or as an attractant. These findings shed
light on the new possibility that Rho- and Rac-dependent
pathways may interact not just in an antagonistic but also in
a cooperative way in the regulation of the timing and the ex-
tent of axon elongation in cultured cerebellar granule cells
(Fig. 10). Our study raises the possibility that the stimulation
of Rho/mDia-mediated pathway by SDF-1  might provide a
modulatory link between the Rho- and Rac-based modes.
Together, these findings underscore the significance of
ROCK/mDia antagonism during early CNS development.
An appropriate balance and coordination between these two
signaling systems may be key to controlling the initial tim-
ing and extent of axon outgrowth as a function of the
strength of stimuli exhibited by the gradient of external
guidance cues such as the pial chemokine SDF-1 .
Materials and methods
Primary culture of mouse cerebellar granule cells
Mouse cerebellar granule cell cultures were as described in Bito et al.
(2000). A detailed protocol can be obtained from the authors upon request.
Materials and reagents
Y-27632, a ROCK inhibitor, was supplied by Dr. Masayoshi Uehata (Mit-
subishi Pharma Co., Osaka, Japan). Botulinum C3 exoenzyme was purified
as described (Morii and Narumiya, 1995). SDF-1  was purchased from
PeproTech EC. GST-Rhotekin RBD and GST-PAK CRIB proteins were pre-
pared as described (Ren et al., 1999; Tsuji et al., 2002). pEGFP-C1 was
from CLONTECH Laboratories, Inc. pEGFP-mDia1 N3, pFL-mDia1 N3,
pEGFP-mDia1 N3 (HindIII), and pEGFP-N17Rac were as described (Wa-
tanabe et al., 1999; Tsuji et al., 2002). All other reagents were of analytical
grade unless noted otherwise.
Transient transfection of plasmid cDNA constructs and 
pharmacological assays
Transfection was performed in the following way as modified from Bito et
al. (2000). At the end of cerebellar granule cell preparation, a cell pellet
was recovered from a 1,000 rpm, 10-min centrifugation at 4 C and resus-
pended with 20% FCS/HANKS( ) at densities of 5   10
5 cells. The cell
mixture (80  l) was plated onto 12-mm round Matrigel-coated (Becton
Dickinson) coverslips (Assistent) placed in a 24-well plate. Each coverslip
had been coated with 80  l Matrigel, 4 h before use. Cells were allowed to
settle down for 30 min at RT and were incubated for 30 min at 37 C in a
CO2 incubator after each coverslip was fed with 0.5 ml of Medium A
(Earle’s MEM supplemented with 10% FCS [Hyclone], 1  B-27 supple-
ment [Invitrogen], insulin [25 mg/L; Sigma-Aldrich], glucose [5 g/L], trans-
ferrin [100 mg/L; Calbiochem], and 2 mM glutamine). Then, for each cov-
erslip subjected to transfection 100  l OptiMEM (Invitrogen) containing a
total amount of 1  g of plasmids (0.5  g of each plasmid for cotransfec-
tion) and 1  l of Lipofectamine 2000 (Invitrogen) was added drop by drop.
The plate was incubated in a CO2 incubator for 3 h and replaced with 0.5
ml of Medium A (same as above) per well. When necessary, either Rho or
ROCK activity was inhibited in transfected cells by adding Y-27632 (final
concentration 50  M) or C3 (final concentration 50  g/ml), respectively.
Cells were put back into a CO2 incubator and cultured for another 12 h.
To examine the effect of various pharmacological reagents on various
aspects of axon outgrowth, cerebellar granule cells were plated onto 12-
mm round Matrigel-coated coverslips placed in a 24-well plate as de-
scribed above. Cells were allowed to settle down for 30 min at RT. After
each coverslip was fed with 0.5 ml of Medium A, they were incubated for
another 3.5 h at 37 C in a CO2 incubator and then replaced with Medium
A supplemented with either the vehicle or SDF-1  (500 ng/ml), Y-27632
(50  M), SDF-1  (10, 100, 250, 500, and 1,000 ng/ml) plus Y-27632 (50
 M), SDF-1  (500 ng/ml) plus C3 (50  g/ml), and indicated concentra-
tions of C3 exoenzyme. The cells were put back into a CO2 incubator and
cultured for another 12 h.
Pharmacological assays were performed in transfected cells in a similar
way except that the cells were incubated in a CO2 incubator for 3 h after
the end of transfection procedure and then replaced with 0.5 ml of Me-
dium A containing similar amounts of drugs as described above.
For transfection, Swiss 3T3 cells were plated on a cover glass at a den-
sity of 2   10
4 cells per 22-mm dish and cultured in DME containing 10%
FCS for 24 h. The cells were washed with PBS( ) once and incubated with
the indicated amounts of pEGFP-C1 or pEGFP-mDia1- N3 mixed with 1
 l of Lipofectamine 2000 for 3 h in 1 ml of OPTI-MEM. The medium was
replaced with DME containing 10% FCS, and the cells were cultured for
18 h. The cells were then cultured in serum-free DME for 24 h and treated
with 30  M Y-27632 for the last 30 min. The cells were fixed and stained
as described below.
Immunofluorescence microscopy and measurements of 
axon parameters
Immunocytochemistry and GFP-imaging was performed essentially as de-
scribed (Bito et al., 1996, 2000) using a LSM 510 system (Carl Zeiss Micro-
Imaging, Inc.). Primary and secondary antibodies were as follows: rabbit
polyclonal anti-p140mDia1 antibody (AP50) (Watanabe et al., 1997), anti-
FLAG mAb (M2; Eastman Kodak Co.), rat antitubulin mAb (Chemicon),
anti– -tubulin mAb (TUB.2.1) (Sigma-Aldrich); anti-GFP monoclonal and
polyclonal (Molecular Probes); and Alexa Fluor 488–, 594–, and 633–con-
jugated goat anti–rabbit, anti–rat, and anti–mouse secondary (Molecular
Probes). Alexa Fluor 594–, and 633–phalloidin (1:1,000; Molecular Probes)
were used to stain the F-actin. In all image analyses, no background sub-
traction was performed, and all pseudocolor representations were assem-
bled using Adobe Photoshop
® version 6.0 for illustrative purpose only.
Quantitation of axon length and number was performed on cerebellar
granule neurons cultured in the presence of 10% FCS using parameters sim-
ilar to those described previously (Bito et al., 2000). Axons were distin-
guished from the filopodia by the presence of microtubules as verified by
 -tubulin staining. As established previously (Bito et al., 2000),  -tubulin im-
munoreactivity was missing in virtually all processes with less than 3  m in
length. Because the average axon number was below two (i.e., exact num-
ber was usually one or zero) during the experimental time window in most
of our assays in this study, we restricted our measurement of axon length to
the longer first process. Since an axon was equal or larger than 3  m in
length, its contour could be unambiguously traced from the cell soma up to
the very tip of the processes; all turning points within the longest process
was defined and the sum of the cumulated distances between these points
was considered as axon length. The calculation was performed off-line us-
ing the software plug-in of the LSM 510 system. Measurements in trans-
fected neurons were performed identically except that transfected neurons
were first identified using an antitag immunostaining (with an anti-GFP or
an anti-FLAG antibody) to maximize the probability of detection; when di-
rectly compared, FLAG- and GFP-tagged constructs yielded similar results
and phenotypes. Statistical analyses were performed using Prism 3.02
(Graphpad Software). All data are indicated as means   SEM. Unpaired t
test with Welch’s correction was employed to determine statistical signifi-
cance and p values below 0.05 was considered as significant.
Videomicroscopy
Cerebellar granule cells labeled with PKH-26 (Sigma-Aldrich) were seeded
at a density of 10
5 per dish in a 35-mm glass-bottom dish (Matsunami
Glass) and cultured for 3 h. The dish was transferred to a temperature-con-
trolled CO2 incubator (Carl Zeiss MicroImaging, Inc.) attached to the mi-
croscope stage. SDF-1  (100 ng/ml, a final concentration) was then added,
and the cell movement was monitored at 37 C in 5% CO2 for 60 min using
a confocal laser scanning unit (LSM 510-V2.5; Carl Zeiss MicroImaging,
Inc.). One optical section was acquired every 3 min, and the video image
were constructed from these sequential images.
Immunohistochemistry
P1 or adult brain was taken out and immediately frozen in TissueTek
O.C.T. Compound (Sakura) on dry ice. Cryostat sections of 20- m width
were obtained and subjected to indirect immunofluorescence staining us-
ing an anti-p140mDia1 primary (AP50; Watanabe et al., 1997) and AlexaT
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Fluor 488–conjugated goat anti–rabbit secondary antibodies. TO-PRO-3
iodide (Molecular Probes) was used for nuclear staining. Specimens were
examined on Axioplan or LSM 510 confocal imaging system (Carl Zeiss
MicroImaging, Inc.). Stacked optical sections were merged using Maxi-
mum Projection Software (Carl Zeiss MicroImaging, Inc.).
Western blot analysis
Total brain or cerebellar tissues were collected from ICR mice of indicated
ages. Thin slices were cut in parasagittal directions in ice-cold HANKS and
lysed in the lysis buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 1  Complete (Protease
Inhibitor Cocktail Tablets) (Roche Diagnostics). The samples were centri-
fuged at 100,000 g for 30 min, and the supernatant was collected as the
cell lysates. Protein concentration of the lysates was determined by the
Lowry method. For Western blot analysis using the total cell lysates, one
fifth volume of the 5  Laemmli sample buffer was added to the lysates.
The mixtures were boiled for 5 min and subjected to SDS-PAGE and West-
ern blot analysis using anti-p140mDia1 antibody (AP50).
Rho and Rac pull-down assays
Cerebellar granule cells were plated at a density of 5   10
5 cells per 10-
cm dish. After treatment with Y-27632, C3 exoenzyme, and/or SDF-1 ,
the cells were washed once with ice-cold HANKS and lysed in the pull-
down lysis buffer containing 50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2
mM MgCl2, 10% glycerol, 1% NP-40, 1  Complete (Roche Diagnostics),
1 mM sodium fluoride, 1 mM EGTA, and 1 mM PMSF. The samples were
centrifuged at 12,000 g for 30 min, and the supernatants were saved as the
cell lysates. For cerebellar tissue lysates, cerebella were collected from P1
and adult ICR mice, and thin slices were cut in parasagittal directions in
ice-cold HANKS and lysed in the pull-down lysis buffer. The tissue lysates
were centrifuged at 100,000 g for 30 min, and the supernatant was col-
lected as the cell lysates. 200  g of cell lysates was incubated with 20  g
GST-Rhotekin RBD or GST-PAK CRIB immobilized on glutathione–
Sepharose 4B beads (Amersham Biosciences) for 1 h at 4 C. Beads were
washed three times with the pull-down buffer, and GTP-bound RhoA and
GTP-bound Rac1 were detected by Western blot with an anti-RhoA (Santa
Cruz Biotechnology, Inc.) and an anti-Rac1 antibody (Upstate Biotechnol-
ogy). Protein concentration was determined by the Lowry method.
Protein knockdown of mDia1 by RNAi using siRNA
siRNA corresponding to mDia1 mRNA sequences were designed as recom-
mended with 5 -phosphate, 3 -hydroxyl, and two-base overhangs on each
strand; it was chemically synthesized and annealed for duplex siRNA for-
mation by Dharmacon Research, Inc. The following gene-specific se-
quences were used successfully: si-mDia1 (K2) sense 5 -GCUGGUCA-
GAGCCAUGGAU-3  and antisense 5 -CGACCAGUCUCGGUACCU-3 .
Transfection of mDia1 siRNA for NIH-3T3 cells (10
4 cells/ml) was per-
formed with Lipofectamine 2000 in 6-well plates. Per well, 2  l lipo-
fectamine 2000 diluted in 100  l Opti-MEM was applied to a premix con-
sisting of siRNA (20  M, 4  l)/Opti-MEM (100  l) and incubated for 30
min. The whole mixture was added to the medium, which then was
changed to DME 3 h after transfection. Cells were incubated for 24–48 h
before analysis of knock-down mDia1 by Western blot as described above.
Cotransfection of pEGFP-C1 and siRNA to cerebellar granule cells (5  
10
5 cells/ml) were performed with Lipofectamine 2000. Briefly, for 10
6
cells 2  l Lipofectamine 2000 diluted in 100  l Opti-MEM was applied to
a pEGFP-C1 (1  g)/siRNA (20  M, 8  l)/Opti-MEM (200  l) mixture and
incubated for 30 min. The entire mixture was then added to the cell-con-
taining medium, which was refed with the original culture medium 3 h af-
ter transfection. Cells were incubated for 12 h in solution and then finally
plated onto 12-mm round Matrigel-coated coverslips placed in a 24-well
plate. After another 12 h of culture on the coverslips, measurements of
axon parameters were performed as described above.
Online supplemental material
Video 1, showing facilitation of axon elongation by a 100 ng/ml SDF-1 
treatment in cultured cerebellar granule neurons, is available online at
http://www.jcb.org/cgi/content/full/jcb.200210149/DC1).
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